Monday, March 30, 2026

Small Caps “Should Do Incredibly Well” In 2023 – With Chris Andrew of Clarmond Wealth

Joining us today on the Daily Dive is Chris Andrew, CEO of Clarmond Wealth. Chris sits with us to discuss commodities, the copper market, his investing strategy, and how small caps can hit it big in 2023.

Clarmond Wealth is a boutique wealth management and investment advisory firm which offers a broad but highly personalized service to families, high net worth individuals and their associated businesses. Clarmond is founded on the principles of service and alignment of interests.


The author has no securities or affiliations related to any organization mentioned. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Antimony Resources Expands New Discovery Following Trenching

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

Related News

George Adams: COVID-19 Damages The Heart – The Daily Dive

Today’s Daily Dive welcomes back Dr. George Adams, Executive Chairman of VentriPoint Diagnostics (TSXV: VPT)....

Friday, September 17, 2021, 01:30:00 PM

$3300 GOLD: Every $100 Rise in Gold Means Pure Profit |  Ross Beaty – Equinox Gold

In this interview, Ross Beaty, Chairman of Equinox Gold (TSX: EQX), examines the current gold...

Monday, June 2, 2025, 01:32:00 PM

Gold Is Now Smart Money’s End Game | Doug Casey

In this interview, Doug Casey provides his analysis on gold price trends and market outlook,...

Sunday, June 22, 2025, 12:28:00 PM

Rick Rule: Gold Market Leadership Starts At The Top – The Daily Dive

Starting off the trading week on the Daily Dive is that of Rick Rule, senior...

Tuesday, February 16, 2021, 01:30:00 PM

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

In this interview David Elsley, CEO of Cardiol Therapeutics (NASDAQ: CRDL) (TSXV: CRDL), shares some...
Monday, August 18, 2025, 03:53:00 PM